Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guam Technology Journal.
Press releases published on August 27, 2025
Snail, Inc. to Present at the 2025 Gateway Conference on September 3, 2025 at 12:30 p.m. Pacific Time
GlobeNewswire
·
August 27, 2025
CULVER CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, is confirmed to present at the 2025 Annual …
Independent Testing Confirms Enovix AI-1™ Battery as Industry’s Highest Energy Density Smartphone Battery
GlobeNewswire
·
August 27, 2025
FREMONT, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced that Polaris Battery Labs, a global provider of independent battery …
Allogene Therapeutics Announces Participation in Upcoming Investor Conference
GlobeNewswire
·
August 27, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …
Lexicon Pharmaceuticals to Participate at Two Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
THE WOODLANDS, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at Citi's Biopharma Back to School Conference on Wednesday, September 3 at 1:45 …
Sarborg Limited Closes $10 Million Seed Round to Expand Proprietary Agentic Approach
GlobeNewswire
·
August 27, 2025
Funding supports next-generation AI agent development and proprietary Intellectual Property, focused initially on pharmaceutical drug-repurposing Initial clients reporting commercial success, revolutionizing indication selection of lead programs Early …
Alluxio Closes Strong Q2 with Customer Growth, Sub-Millisecond Latency Capability for AI Data & Record MLPerf Storage v2.0 Benchmark Results
GlobeNewswire
·
August 27, 2025
SAN MATEO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alluxio, the AI and data-acceleration platform, today announced strong results for the second quarter of its 2026 fiscal year. During the quarter, the company launched Alluxio Enterprise AI 3.7, a major …
ODYSIGHT.AI TO PARTICIPATE IN THE H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE
GlobeNewswire
·
August 27, 2025
OMER, Israel, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Odysight.AI Inc. (Nasdaq: ODYS), a leading developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), today announced that Einav Brenner, Chief Financial Officer, will …
24/7 Market News: LIXTE Showcases LB-100 at First Global Conference on Oncogenic Signaling Activation as Cancer Therapy
GlobeNewswire
·
August 27, 2025
DENVER, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, highlights the publication of a new manuscript in Trends in Cancer (July 2025, …
Kailera Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity, today announced …
Cellectar Biosciences to Present Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
GlobeNewswire
·
August 27, 2025
FLORHAM PARK, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the acceptance …
24/7 Market News: Kraig Labs Prepares for High-Profile International Order as Second Production Facility Reaches Full Operational Status
GlobeNewswire
·
August 27, 2025
DENVER, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and insights, reports that Kraig Biocraft Laboratories (OTCQB: KBLB)(“Kraig Labs” or “the Company”), the …
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
GlobeNewswire
·
August 27, 2025
US Food and Drug Administration (FDA) has granted Fast Track designation for NRX-100 in the treatment of suicidal ideation in patients with depression, including bipolar depression. NRx Pharmaceuticals is making NRX-100 available on an expanded access …
Evaxion to present at several conferences during the second half of 2025
GlobeNewswire
·
August 27, 2025
Evaxion will provide scientific and company updates at numerous conferences in both the US, Europe and Asia during the coming months COPENHAGEN, Denmark, August 27, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company …
Aclaris Therapeutics to Participate in Two September Healthcare Conferences
GlobeNewswire
·
August 27, 2025
WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will …
Annexon Biosciences to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 27, 2025
BRISBANE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
PHILADELPHIA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune …
Acronis and Intel Partner to Deliver Efficient, AI-Driven Threat Detection for Endpoint Devices
GlobeNewswire
·
August 27, 2025
SCHAFFHAUSEN, Switzerland, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, and Intel, today announced Acronis Cyber Protect Cloud’s availability with AI PCs powered by Intel Core Ultra processors, a new …
Soleno Therapeutics to Participate in Upcoming September Conferences
GlobeNewswire
·
August 27, 2025
REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the …
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living …
Septerna to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that management will participate …